Skip to content

Vertex Pharmaceuticals VRTX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin86.2%0.0pp86.2%0.0pp86.3%+0.2pp86.1%+0.1pp86%-0.1pp
Operating margin38.3%+3.5pp34.8%
Net margin35.5%+2.6pp32.9%
Returns
Return on equity24.2%+1.7pp22.5%
Return on invested capital26.8%+2.5pp24.3%-1.4pp25.7%-1.3pp27%+32.4pp-5.3%-4.8pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio+0.1×2.9×+0.5×2.4×-0.2×2.5×-0.1×2.6×0.0×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-0.7×0.0×-0.7×0.0×-0.7×+0.1×-0.8×
Per Share
Book value per share$75.54+4.4%$72.35+7.6%$67.23+1.3%$66.34+4.4%$63.57-0.1%
Valuation
Market capitalization$113.44B-1.4%$115.03B+14.6%$100.41B-13.2%$115.63B-7.1%$124.5B+20.0%
Price / earnings26.1×-2.9×29.1×
Price / sales9.3×-0.3×9.6×+1.0×8.6×-1.6×10.1×-1.1×11.2×+1.8×
Price / book5.9×-0.3×6.2×+0.4×5.8×-0.9×6.7×-0.8×7.5×+1.2×
EV / EBITDA22.4×-3.1×25.5×+3.0×22.6×-3.9×26.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Vertex Pharmaceuticals's profit margins?
Vertex Pharmaceuticals (VRTX) runs a 86.2% gross margin and a 38.3% operating margin, with a 35.5% net margin.
Where do Vertex Pharmaceuticals's ratios come from?
Every ratio is computed from Vertex Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.